Kiniksa Pharmaceuticals L...

NASDAQ: KNSA · Real-Time Price · USD
33.26
-0.02 (-0.06%)
At close: Aug 15, 2025, 3:05 PM

Kiniksa Pharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-32.71 87.25 5.67 -5.11
PEG Ratio
0.08 -0.94 -0.03 0.43
PS Ratio
3.34 4.55 4.72 20.94
PB Ratio
3.22 2.80 -2.11 -1.2
P/FCF Ratio
55.59 93.30 182.28 -5.5
P/OCF Ratio
55.00 92.39 178.98 -6.39
OCF/S Ratio
0.06 0.05 0.03 -3.28
Debt / Equity Ratio
0.02 0.03 -0.01 -0.01
Quick Ratio
3.04 3.85 4.71 4.30
Current Ratio
3.30 4.34 5.16 4.38
Asset Turnover
0.73 0.51 0.48 0.17
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-0.1 0.03 -0.37 0.23
Return on Assets
-0.07 0.03 0.40 -0.68
Return on Invested Capital
-0.11 0.05 0.29 -0.81
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.86 0.79 0.79 0.76
Net Profit Margin
-0.1 0.05 0.83 -4.1
Pretax Profit Margin
-0.09 -0.06 0.05 -4.06
Operating Profit Margin
-0.11 -0.09 0.03 -4.06
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-0.11 -0.08 0.04 -4